Table 2.

Response evaluation at first radiological assessment (n = 59)

	Olaparib arm (n = 32)			Placebo arm (n = 27)
	N	%	IC 95%	N	%	IC 95%
Objective response	2	6.3	[0.8–20.8]	3	11.1	[2.4–29.2]
Disease control	15	46.9	[29.1–65.3]	10	37	[19.4–57.6]
Complete response	0	0	-	0	0	-
Partial response	2	6.3	[0.8–20.8]	3	11.1	[2.4–29.2]
Stable disease	13	40.6	[23.7–59.4]	7	25.9	[11.1–46.3]
Progression	17	53.1	[34.7–70.9]	17	63	[42.4–80.6]